Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Aquestive Therapeutics, Inc.

AQST · Nasdaq · CIK 0001398733 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

24 Form 4 transaction lines observed in the same window
9 sales · 15 option, withholding, award, gift or other lines

Last qualifying purchase2022-06-14 · Boyd Peter E. · $4.1K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Barber DanielPresident and CEO
○▼▼▼▼▼○▼▼
Korczynski SherryChief Commercial Officer
○○○▼
Boyd Peter E.Chief People Officer
○○
Jung CassieChief Operating Officer
○○
Krop JulieDirector
○▼
BRAENDER LORI JCorporate Secretary
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-06-14 · Boyd Peter E..

Recent Form 4 activity

0Purchases
16Sales
27Other Form 4 lines
33SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING9 sale line(s) · context only
OTHER15 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-11.3%
3M
+9.0%
6M
+10.5%
12M
-22.6%

Volatility & liquidity

Volatility
76.3%
Beta
1.49
Avg daily value
USD 12.3M

Valuation

Market cap
USD 579.9M
P/E
—

Fundamentals

Profit margin
-188.1%
ROE
—
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-07 · Price source: OpenBB/yfinance · From SEC filings: Profit margin · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
28,748,212
Previous report
27,161,738
Avg daily volume
2,201,111
Days to cover
13.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-06-14Boyd Peter E.Purchase (P)Common Stock5,000USD 0.81USD 4,050SEC filing ↗
2022-06-08Schobel Alexander MarkPurchase (P)Common Stock45,871USD 0.96USD 44,036SEC filing ↗
2022-06-08Boyd Peter E.Purchase (P)Common Stock2,293USD 0.96USD 2,201SEC filing ↗
2022-06-08Barber DanielPurchase (P)Common Stock91,743USD 0.96USD 88,073SEC filing ↗
2022-06-08BRAENDER LORI JPurchase (P)Common Stock13,761USD 0.96USD 13,211SEC filing ↗
2020-03-16Boyd Peter E.Purchase (P)Common Stock2,000USD 1.50USD 3,000SEC filing ↗
2020-03-16BRAENDER LORI JPurchase (P)Common Stock14,000USD 1.54USD 21,560SEC filing ↗

Form 4 evidence

43 transaction lines in the latest 365-day window; 167 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Barber DanielSale (S)Common Stock25,000USD 4.22USD 105,600SEC filing ↗
2026-09-15Barber DanielSale (S)Common Stock25,000USD 4.82USD 120,500SEC filing ↗
2026-09-09Korczynski SherrySale (S)Common Stock8,750USD 5.22USD 45,675SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Barber DanielSale (S)Common Stock25,000USD 4.22USD 105,600SEC filing ↗
2026-09-15Barber DanielSale (S)Common Stock25,000USD 4.82USD 120,500SEC filing ↗
2026-09-09Korczynski SherrySale (S)Common Stock8,750USD 5.22USD 45,675SEC filing ↗
2026-09-09Korczynski SherryOption exercise / conversion (M)Common Stock8,750USD 2.65USD 23,188SEC filing ↗
2026-09-09Boyd Peter E.X (X)Common Stock2,293USD 0.96USD 2,201SEC filing ↗
2026-09-08Barber DanielX (X)Common Stock91,743USD 0.96USD 88,073SEC filing ↗
2026-09-03Jung CassieX (X)Common Stock4,587USD 0.96USD 4,404SEC filing ↗
2026-08-17Barber DanielSale (S)Common Stock25,000USD 4.29USD 107,250SEC filing ↗
2026-08-14Korczynski SherryTax withholding (F)Common Stock2,714USD 4.25USD 11,534SEC filing ↗
2026-07-16Barber DanielSale (S)Common Stock20,369USD 4.00USD 81,476SEC filing ↗
2026-07-15Barber DanielSale (S)Common Stock4,631USD 4.03USD 18,663SEC filing ↗
2026-06-23Krop JulieSale (S)Common Stock25,000USD 5.02USD 125,500SEC filing ↗
2026-06-23Krop JulieOption exercise / conversion (M)Common Stock25,000USD 0.71USD 17,750SEC filing ↗
2026-06-15Barber DanielSale (S)Common Stock25,000USD 4.16USD 104,000SEC filing ↗
2026-06-08Korczynski SherryTax withholding (F)Common Stock2,714USD 0.00USD 0SEC filing ↗
2026-05-18Zalewski Thomas A.Award / grant (A)Common Stock100,000USD 0.00USD 0SEC filing ↗
2026-05-15Cioffi MelinaTax withholding (F)Common Stock1,667USD 4.17USD 6,951SEC filing ↗
2026-05-15Barber DanielSale (S)Common Stock8,257USD 4.29USD 35,423SEC filing ↗
2026-05-07BRAENDER LORI JTax withholding (F)Common Stock135,690USD 4.23USD 573,969SEC filing ↗
2026-05-05TOTH A ERNEST JRTax withholding (F)Common Stock92,652USD 4.18USD 387,285SEC filing ↗
2026-05-05Jung CassieTax withholding (F)Common Stock72,734USD 4.18USD 304,028SEC filing ↗
2026-05-05Boyd Peter E.Tax withholding (F)Common Stock56,778USD 4.18USD 237,332SEC filing ↗
2026-05-05Barber DanielTax withholding (F)Common Stock335,922USD 4.18USD 1,404,154SEC filing ↗
2026-05-05BRAENDER LORI JTax withholding (F)Common Stock76,147USD 4.18USD 318,294SEC filing ↗
2026-03-10TOTH A ERNEST JRSale (S)Common Stock58,254USD 4.17USD 242,919SEC filing ↗
2026-03-10Korczynski SherrySale (S)Common Stock15,741USD 4.17USD 65,640SEC filing ↗
2026-03-10Jung CassieSale (S)Common Stock45,791USD 4.17USD 190,948SEC filing ↗
2026-03-10Cioffi MelinaSale (S)Common Stock25,311USD 4.17USD 105,547SEC filing ↗
2026-03-10Boyd Peter E.Sale (S)Common Stock29,814USD 4.17USD 124,324SEC filing ↗
2026-03-10Barber DanielSale (S)Common Stock180,677USD 4.17USD 753,423SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAQST
CIK0001398733
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history167 transaction lines from 2020-02-29 to 2026-10-15
7 P purchase lines · 36 S sale lines · 124 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.